Head and neck squamous cell carcinoma
DE Johnson, B Burtness, CR Leemans… - Nature reviews Disease …, 2020 - nature.com
Most head and neck cancers are derived from the mucosal epithelium in the oral cavity,
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma …
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma …
Therapeutic targeting of the hypoxic tumour microenvironment
DC Singleton, A Macann, WR Wilson - Nature reviews Clinical oncology, 2021 - nature.com
Hypoxia is prevalent in human tumours and contributes to microenvironments that shape
cancer evolution and adversely affect therapeutic outcomes. Historically, two different …
cancer evolution and adversely affect therapeutic outcomes. Historically, two different …
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
A Elmusrati, J Wang, CY Wang - International journal of oral science, 2021 - nature.com
Head and neck squamous cell carcinoma (HNSCC), an aggressive malignancy, is
characterized by high morbidity and low survival rates with limited therapeutic options …
characterized by high morbidity and low survival rates with limited therapeutic options …
Nanoparticle‐mediated radiotherapy remodels the tumor microenvironment to enhance antitumor efficacy
W Zhen, RR Weichselbaum, W Lin - Advanced Materials, 2023 - Wiley Online Library
Radiotherapy (RT) uses ionizing radiation to eradicate localized tumors and, in rare cases,
control tumors outside of the irradiated fields via stimulating an antitumor immune response …
control tumors outside of the irradiated fields via stimulating an antitumor immune response …
Tumor hypoxia regulates immune escape/invasion: influence on angiogenesis and potential impact of hypoxic biomarkers on cancer therapies
R Abou Khouzam, K Brodaczewska, A Filipiak… - Frontiers in …, 2021 - frontiersin.org
The environmental and metabolic pressures in the tumor microenvironment (TME) play a
key role in molding tumor development by impacting the stromal and immune cell fractions …
key role in molding tumor development by impacting the stromal and immune cell fractions …
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
S Zheng, Y Zou, Y Tang, A Yang, JY Liang, L Wu… - …, 2022 - Taylor & Francis
Cancer-associated fibroblasts (CAFs) are essential for tumor microenvironment remodeling
and correlate with tumor progression. However, interactions between CAFs and tumor cells …
and correlate with tumor progression. However, interactions between CAFs and tumor cells …
Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell …
S Zheng, JY Liang, Y Tang, J Xie, Y Zou… - Clinical and …, 2023 - Wiley Online Library
Abstract Introduction Cancer‐associated fibroblasts (CAFs) are correlated with the
immunotherapy response. However, the culprits that link CAFs to immunotherapy resistance …
immunotherapy response. However, the culprits that link CAFs to immunotherapy resistance …
[HTML][HTML] Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
DP Zandberg, AV Menk, M Velez… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
The majority of patients with recurrent/metastatic squamous cell carcinoma of the head and
neck (HNSCC)(R/M) do not benefit from anti-PD-1 therapy. Hypoxia induced …
neck (HNSCC)(R/M) do not benefit from anti-PD-1 therapy. Hypoxia induced …
Hypoxia and the phenomenon of immune exclusion
V Pietrobon, FM Marincola - Journal of Translational Medicine, 2021 - Springer
Over the last few years, cancer immunotherapy experienced tremendous developments and
it is nowadays considered a promising strategy against many types of cancer. However, the …
it is nowadays considered a promising strategy against many types of cancer. However, the …
Tumour hypoxia-mediated immunosuppression: mechanisms and therapeutic approaches to improve cancer immunotherapy
The magnitude of the host immune response can be regulated by either stimulatory or
inhibitory immune checkpoint molecules. Receptor-ligand binding between inhibitory …
inhibitory immune checkpoint molecules. Receptor-ligand binding between inhibitory …